Market Overview:
The global continuous flow apheresis device market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in apheresis devices. Based on type, the plasma separators segment is expected to account for the largest share of the global continuous flow apheresis device market in 2018. This segment is also projected to grow at a CAGR of 7.8% from 2018 to 2030. The large share and high growth rate of this segment can be attributed to factors such as increasing demand for plasma-derived products and growing number of patients with hemophilia A & B worldwide. Based on application, therapeutic plasma exchange (TPE) is expected to account for the largest share of the global continuous flow apheresis device market in 2018.
Product Definition:
A continuous flow apheresis device is a medical device that is used to separate blood cells from plasma. The device uses a centrifuge to spin the blood cells and plasma apart. The separated blood cells are then returned to the patient, and the plasma is collected in a bag for later use.
Plasma Separators:
Plasma separators are used in continuous flow apheresis devices to remove blood components. Plasma separation is a process of removing the cellular elements from whole blood by using a plasma expulsor and a plasma separator. The two major types of products obtained after this process are termed as fresh frozen plasma (FFP) and dried, concentrated, ready-to-use (DCFP) hemophilia products.
Plasma Component Separators:
Plasma component separators are used in continuous flow apheresis devices for the separation of blood into RBC, WBC, platelets and plasma. Continuous Flow Apheresis (CFA) is a process where there is separation of components in blood by their density. Plasma being the denser fluid separates from other fluids during CFA procedure.
Application Insights:
Therapeutic plasma exchange (TPE) accounted for the largest share of over 50.0% in 2017 owing to its wide application in the treatment of various blood disorders, such as polycythemia, primary immunodeficiency diseases and Addison disease. TPE is also used for the treatment of other disorders where there is a deficiency or reduction in white blood cells production.
Continuous flow apheresis devices are widely used for therapeutic cytapheresis due to its ability to deliver precise and controlled amounts of donor blood components within a specific time frame while maintaining hemovigilance properties. It has been found that this method reduces adverse effects compared with conventional methods such as RBC Transfusion Therapy or bone marrow transplantation procedures which have led to an increase in adoption across hospitals and clinical settings worldwide.
Regional Analysis:
North America dominated the global continuous flow apheresis device market in 2017. This can be attributed to the presence of a large number of manufacturers, collaborative agreements, and research & development activities. The region is expected to maintain its dominance throughout the forecast period owing to technological advancements and increasing R&D investments by companies.
The Asia Pacific is anticipated to grow at a lucrative rate over the forecast period due to an increase in healthcare expenditure by governments along with rising awareness about blood donation procedures among people. Moreover, growing medical tourism industry will also boost demand for these devices in this region thereby driving growth during the forecast period from 2018-2030 (USD Million).
In addition, favorable government initiatives are also expected favorably impact market growth during this time frame as they aim at promoting blood donations among population which further leads towards reduction of plasma component requirements thus positively influencing CFA devices market growth in near future (USD Million).
Growth Factors:
- Increasing incidence of chronic diseases such as cancer, renal failure, and autoimmune disorders is expected to drive the demand for continuous flow apheresis devices over the forecast period.
- Growing popularity of minimally invasive procedures is anticipated to boost the adoption of continuous flow apheresis devices across hospitals and clinics worldwide.
- Technological advancements in apheresis devices are likely to result in increased efficiency and accuracy of treatment procedures, which will propel market growth over the next few years.
- Rising number of patients suffering from blood disorders is projected to create a positive impact on market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Continuous Flow Apheresis Device Market Research Report
By Type
Plasma Separators, Plasma Component Separators, Immunoadsorption Columns, Plasma Perfusion Columns, Hemoperfusion Columns
By Application
Therapeutic Plasma Exchange(TPE), Therapeutic Cytapheresis, Photopheresis, Extracorporeal Immunoadsorption(ECI)
By Companies
Fresenius Medical Care(Germany), B. Braun Melsungen AG(Germany), HemaCare Corporation(US), Kaneka Corporation(Japan), Nikkiso Co., Ltd.(Japan), Terumo BCT, Inc(US), Haemonetics Corporation(US), Asahi Kasei Medical Co., Ltd.(Japan), Kawasumi Laboratories Inc.(Japan), Cerus Corporation(US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
207
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Continuous Flow Apheresis Device Market Report Segments:
The global Continuous Flow Apheresis Device market is segmented on the basis of:
Types
Plasma Separators, Plasma Component Separators, Immunoadsorption Columns, Plasma Perfusion Columns, Hemoperfusion Columns
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Therapeutic Plasma Exchange(TPE), Therapeutic Cytapheresis, Photopheresis, Extracorporeal Immunoadsorption(ECI)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius Medical Care(Germany)
- B. Braun Melsungen AG(Germany)
- HemaCare Corporation(US)
- Kaneka Corporation(Japan)
- Nikkiso Co., Ltd.(Japan)
- Terumo BCT, Inc(US)
- Haemonetics Corporation(US)
- Asahi Kasei Medical Co., Ltd.(Japan)
- Kawasumi Laboratories Inc.(Japan)
- Cerus Corporation(US)
Highlights of The Continuous Flow Apheresis Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Plasma Separators
- Plasma Component Separators
- Immunoadsorption Columns
- Plasma Perfusion Columns
- Hemoperfusion Columns
- By Application:
- Therapeutic Plasma Exchange(TPE)
- Therapeutic Cytapheresis
- Photopheresis
- Extracorporeal Immunoadsorption(ECI)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Continuous Flow Apheresis Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Continuous Flow Apheresis Device (CFA) is a medical device that removes blood from the body by passing it through a series of filters. The CFA helps to reduce the amount of time needed for blood transfusions, which can be lifesaving in cases of an emergency.
Some of the major companies in the continuous flow apheresis device market are Fresenius Medical Care(Germany), B. Braun Melsungen AG(Germany), HemaCare Corporation(US), Kaneka Corporation(Japan), Nikkiso Co., Ltd.(Japan), Terumo BCT, Inc(US), Haemonetics Corporation(US), Asahi Kasei Medical Co., Ltd.(Japan), Kawasumi Laboratories Inc.(Japan), Cerus Corporation(US).
The continuous flow apheresis device market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Continuous Flow Apheresis Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Continuous Flow Apheresis Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Continuous Flow Apheresis Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Continuous Flow Apheresis Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Continuous Flow Apheresis Device Market Size & Forecast, 2020-2028
4.5.1 Continuous Flow Apheresis Device Market Size and Y-o-Y Growth
4.5.2 Continuous Flow Apheresis Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Plasma Separators
5.2.2 Plasma Component Separators
5.2.3 Immunoadsorption Columns
5.2.4 Plasma Perfusion Columns
5.2.5 Hemoperfusion Columns
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Therapeutic Plasma Exchange(TPE)
6.2.2 Therapeutic Cytapheresis
6.2.3 Photopheresis
6.2.4 Extracorporeal Immunoadsorption(ECI)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Continuous Flow Apheresis Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Continuous Flow Apheresis Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Plasma Separators
9.6.2 Plasma Component Separators
9.6.3 Immunoadsorption Columns
9.6.4 Plasma Perfusion Columns
9.6.5 Hemoperfusion Columns
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Therapeutic Plasma Exchange(TPE)
9.10.2 Therapeutic Cytapheresis
9.10.3 Photopheresis
9.10.4 Extracorporeal Immunoadsorption(ECI)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Plasma Separators
10.6.2 Plasma Component Separators
10.6.3 Immunoadsorption Columns
10.6.4 Plasma Perfusion Columns
10.6.5 Hemoperfusion Columns
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Therapeutic Plasma Exchange(TPE)
10.10.2 Therapeutic Cytapheresis
10.10.3 Photopheresis
10.10.4 Extracorporeal Immunoadsorption(ECI)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Plasma Separators
11.6.2 Plasma Component Separators
11.6.3 Immunoadsorption Columns
11.6.4 Plasma Perfusion Columns
11.6.5 Hemoperfusion Columns
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Therapeutic Plasma Exchange(TPE)
11.10.2 Therapeutic Cytapheresis
11.10.3 Photopheresis
11.10.4 Extracorporeal Immunoadsorption(ECI)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Plasma Separators
12.6.2 Plasma Component Separators
12.6.3 Immunoadsorption Columns
12.6.4 Plasma Perfusion Columns
12.6.5 Hemoperfusion Columns
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Therapeutic Plasma Exchange(TPE)
12.10.2 Therapeutic Cytapheresis
12.10.3 Photopheresis
12.10.4 Extracorporeal Immunoadsorption(ECI)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Plasma Separators
13.6.2 Plasma Component Separators
13.6.3 Immunoadsorption Columns
13.6.4 Plasma Perfusion Columns
13.6.5 Hemoperfusion Columns
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Therapeutic Plasma Exchange(TPE)
13.10.2 Therapeutic Cytapheresis
13.10.3 Photopheresis
13.10.4 Extracorporeal Immunoadsorption(ECI)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Continuous Flow Apheresis Device Market: Competitive Dashboard
14.2 Global Continuous Flow Apheresis Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fresenius Medical Care(Germany)
14.3.2 B. Braun Melsungen AG(Germany)
14.3.3 HemaCare Corporation(US)
14.3.4 Kaneka Corporation(Japan)
14.3.5 Nikkiso Co., Ltd.(Japan)
14.3.6 Terumo BCT, Inc(US)
14.3.7 Haemonetics Corporation(US)
14.3.8 Asahi Kasei Medical Co., Ltd.(Japan)
14.3.9 Kawasumi Laboratories Inc.(Japan)
14.3.10 Cerus Corporation(US)
